Audience seated in a conference auditorium, viewed from behind, facing the stage.
Events

Better decisions start with a conversation

We partner with life sciences and health system teams to generate integrated evidence continuously, and some of the best conversations start at a conference. Find the meeting you're attending below and bring us your questions. We'd love to hear what your program is working toward.

Upcoming meetings

Effect of varying pre-interruption periods on interrupted time series estimates and interpretation: a simulation study

Where: Spotlight Poster

When: B-284

Tue 1 Sep

Rachel Faller · with Nuvan Rathnayaka

Let us know you're coming →

Estimating recurrent complication burden under time-varying risk: a comparison of Poisson regression and the partitioned count estimator

Where: Poster

When: C-439

Wed 2 Sep

Yasmmyn Salinas · with Teresa Bufford, Derek Gazis, Julie Crawford, Kathleen Hurwitz, Alan Brookhart

Let us know you're coming →

Standard error estimation for transported effects in sequential nested trial emulations using M-estimation

Where: Poster

When: C-350

Wed 2 Sep

Catie Wiener · with Chase Latour, Jeanny Wang, Paul Zivich, Alan Brookhart

Let us know you're coming →

Regional and variant-era variation in treatment patterns and remdesivir use among immunocompromised patients hospitalized with COVID-19: an analysis of polypharmacy using UpSet plots

Where: Poster

When: C-123

Wed 2 Sep

Kayla Hendrickson · with Nuvan Rathnayaka, Mark Berry (Gilead), Carrie Nielson (Gilead), Alan Brookhart, Kathleen Hurwitz

Let us know you're coming →
Official AASLD mark on white, for The Liver Meeting 2026 events listing card.

AASLD The Liver Meeting 2026

Where: Denver, Colorado

When: November 5 – 9, 2026

Booth 1968

Liver disease is where our roots run deepest. Our hepatology cohorts, derived from an activated site network, and scientific team will be at The Liver Meeting all week. We're excited about the conversations happening across the field right now, from MASH to cholestatic liver diseases on what post-approval evidence should look like.

Who should stop by:

Hepatology clinical development, medical affairs, and HEOR teams building or rethinking an evidence plan

Health systems and investigators interested in our site network

Anyone who wants to talk liver disease evidence over coffee

Let us know you're coming →

Attending somewhere we haven't listed?

Tell us which meeting you're attending and what your team is working on. If we'll be there, we'll set up time with the right people. If we won't, we'll start the conversation anyway. Every integrated evidence plan begins with a question, so bring yours.

By submitting this form, you agree to Pedestal Health contacting you about your inquiry. See our Privacy Policy.

This form is protected by reCAPTCHA. Privacy & Terms